Alembic Pharmaceuticals’ Q1 consolidated net profit registers 45% growth

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2016.

The company has reported 53.22% rise in its net profit after tax at Rs 119.74 crore for the quarter ended June 30, 2016 as compared to Rs 78.15 crore for the same quarter in the previous year. The company’s total income increased by 20.01% to Rs 688.98 crore for the quarter under review from Rs 574.10 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 44.64% rise in its net profit after taxes and share of profit of associates at Rs 103.75 crore for the quarter ended June 30, 2016 as compared to Rs 71.73 crore for the same quarter in the previous year. Total Income of the company increased by 25.04% to Rs 728.42 crore for the quarter under review from Rs 582.57 crore for the same quarter ended June 30, 2015.